TCV-309 is an inhibitor of platelet activating factor (PAF). TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia. TCV-309 attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. TCV-309 inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.
Molecular Weight:
656.52
CAS Number:
[131311-25-6]
Formula:
C30H34BrN5O7
Target:
Others
T28933
* VAT and and shipping costs not included. Errors and price changes excepted